Conference Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details

233 * ! Tue, 8/9/2022, 8:30 AM - 10:20 AM CC-144B
Statistical Considerations for Adjusting Overall Survival in Randomized Trials with Treatment Switching — Topic Contributed Papers
Biopharmaceutical Section, Biometrics Section, International Statistical Institute
Organizer(s): Songzi Li, BeiGene, Ltd.
Chair(s): Jiang Li, Ph.D
8:35 AM A Simulation Study of Treatment Switching Considering Delay Treatment Effect
Songzi Li, BeiGene, Ltd.; Jiang Li, Ph.D
8:55 AM The Least Bad Option: A Simulation Approach to Minimizing Bias When Accounting for Treatment Switching in RCTs
Daniel Leibovitz, Bristol Myers Squibb; Alessandro Previtali, Bristol Myers Squibb; Revathi Ananthakrishnan, Bristol Myers Squibb; James Lymp, Bristol Myers Squibb
9:15 AM Estimation of Treatment Effects and Model Diagnostics with Two-Way, Time-Varying Treatment Switching
Qingxia Chen, Vanderbilt University Medical Center; Fan Zhang, Pfizer Inc., Groton, CT. This work was done at University of Connecticut.; Ming-Hui Chen, University of Connecticut; Xiuyu Julie Cong, Everest Medicines, Shanghai, China. This work was done at Boehringer Ingelheim Pharma.
9:35 AM Bayesian Model for Overall Survival Analysis Allowing Treatment Switching in Oncology Trials
Zhou Feng, FDA; Erik Bloomquist, Ph.D.
9:55 AM Discussant: Chi Song, FDA
10:15 AM Floor Discussion